Location: You are the clerking FY1 on the acute medical take
Patient: 75 year old patient has come into A&E with increasing shortness of breath
Task:
– Take a focused history from the patient
– After 6 minutes you will be asked a series of questions by the examiner.
– Answer any questions that the patient may have
| Mark sheet | 😊 | 😃 |
|---|---|---|
| Candidate appropriately introduced themselves with: | 3 | 4 |
| Explores presenting complaint | 2 | 4 |
Pass
Fail
Your percentage
Average user score for this station
Station pass mark
Feedback
Focus the history on change from baseline
- The key finding is the decline from walking about 200 metres to struggling between bed and chair. Establish the time course, breathlessness at rest, ability to speak and manage daily activities, and response to the increasingly frequent blue inhaler. Severe breathlessness should prompt immediate observations and clinical assessment rather than waiting to finish the history.
- Ask about changes in cough, sputum volume and colour, wheeze, fever and chest pain. Chronic cough, recurrent episodes labelled as chest infections and a 45 pack-year smoking history strongly suggest underlying COPD, but previous inhaler use alone does not establish the diagnosis.
- Explore the practical impact: stairs, shopping, housework and available support. The patient's fear of needing residential care matters. Explain that an acute deterioration does not automatically mean permanent loss of independence; recovery and support needs should be assessed before discharge.
Connect the findings to the diagnosis
- The leading diagnosis is an acute exacerbation of suspected COPD, most likely non-infective in this station. Increased airway inflammation, mucus and airflow obstruction cause air trapping and greater work of breathing. Clear sputum, no reported fever, normal inflammatory markers and no focal consolidation make bacterial infection less likely, but do not exclude infection completely.
- Keep heart failure and pulmonary embolism in mind. The absence of orthopnoea, paroxysmal nocturnal dyspnoea and leg swelling makes heart failure less likely. Lack of obvious thromboembolic risk factors does not rule out PE: reconsider it if breathlessness or hypoxaemia is disproportionate, particularly with pleuritic pain, tachycardia or poor response to treatment.
- Confirm COPD with post-bronchodilator spirometry when clinically stable: an FEV1/FVC ratio below 0.70 supports persistent airflow obstruction in the appropriate clinical context. Chest radiography supports the assessment but does not confirm COPD by itself.
Interpret the investigations in context
- Chest X-ray: the lungs appear hyperinflated and hyperlucent, with low, flattened diaphragms and a narrow cardiac silhouette, supporting emphysematous change. There is no obvious focal air-space consolidation. Imaging also helps identify alternative or additional causes of deterioration, such as pneumonia or pneumothorax.
- Blood results: WBC 5.0 × 10⁹/L, neutrophils 2.0 × 10⁹/L and CRP below 4 mg/L show no raised inflammatory response. Haemoglobin is 116 g/L, within the supplied reference range, and electrolytes and liver tests are within their listed ranges. eGFR is mildly below the laboratory reference at 83 mL/min/1.73 m²; this isolated result does not establish chronic kidney disease.
- Obtain observations, oxygen saturation, an ECG and an arterial blood gas in this hospital presentation to assess oxygenation, carbon dioxide retention and pH, recording any oxygen being administered. D-dimer should follow a clinical probability assessment for PE rather than be a routine screen; natriuretic peptide testing is useful when heart failure remains suspected.
Treat the exacerbation and reassess
- Start with an ABCDE assessment and prompt inhaled short-acting bronchodilators, using a spacer or nebuliser according to severity and ability to use the device. If oxygen is required, give controlled oxygen, usually targeting 88–92% initially pending blood gases and individual review. Oxygen treats hypoxaemia, not breathlessness alone.
- The steroid prescription assessed here is prednisolone 30 mg orally once daily for 5 days, after checking contraindications and relevant risks such as hyperglycaemia. Steroids shorten recovery, but do not replace bronchodilators. Antibiotics are not automatic: assess sputum purulence, clinical severity and evidence of bacterial infection.
- Reassess respiratory rate, work of breathing, saturation, mental state and treatment response; repeat blood gases when indicated. Improvement means easier breathing and improving function, not merely a satisfactory saturation. Exhaustion, drowsiness, worsening hypoxaemia or persistent hypercapnic acidosis despite initial treatment require urgent senior review; non-invasive ventilation may be needed.
Plan beyond the acute episode
- Before discharge, review inhaler technique and maintenance treatment, offer smoking-cessation support, and arrange stable-state spirometry and follow-up. Consider pulmonary rehabilitation after recovery and provide a clear exacerbation action plan.
- Check that mobility, stair use and daily activities are manageable with appropriate support. Recovery can take weeks, so acknowledge the patient's concerns without promising an immediate return to baseline.